The July 2026 FDA Advisory Votes on BPC-157, TB-500, MOTS-c and Semax: What Changed and What Did Not
An FDA advisory committee recommended six peptides for the 503A compounding list in July 2026. Here is what a non-binding vote does, and does not, mean.